Financhill
Back

Theravance Biopharma Quote, Financials, Valuation and Earnings

Theravance Biopharma Price Quote

$9.62
+0.02 (+-1.13%)
(Updated: December 21, 2024 at 5:49 AM ET)

Theravance Biopharma Key Stats

Buy
51
Theravance Biopharma (TBPH) is a Buy

Day range:
$9.56 - $9.83
52-week range:
$7.44 - $11.71
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.42
P/B ratio:
2.54%

Volume:
310.2K
Avg. volume:
228.5K
1-year change:
-12.49%
Market cap:
$472.1M
Revenue:
$57.4M
EPS:
$-1.01

How Much Does Theravance Biopharma Make?

Data Unavailable

Is Theravance Biopharma Growing As A Company?

Data Unavailable

Theravance Biopharma Stock Price Performance

What Is Theravance Biopharma 52-Week High & Low?

Theravance Biopharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Theravance Biopharma?

Data Unavailable

Is Theravance Biopharma Cash Flow Positive?

Data Unavailable

Theravance Biopharma Return On Invested Capital

Data Unavailable

Theravance Biopharma Earnings Date & Stock Price

Theravance Biopharma Competitors

  • Who Are Theravance Biopharma's Competitors?
    Below is a list of companies who compete with Theravance Biopharma or are related in some way:
    • Corcept Therapeutics Inc (CORT)
    • Ionis Pharmaceuticals Inc (IONS)
    • Jazz Pharmaceuticals PLC (JAZZ)
    • Madrigal Pharmaceuticals Inc (MDGL)
    • NovaBay Pharmaceuticals Inc (NBY)

Theravance Biopharma Dividend Yield

Data Unavailable

Theravance Biopharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 42.9%
Revenue: 7.49% 9.37%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable